{"title":"我们应该在搅拌良好的模型中使用哪个未结合的部分来更准确地预测人类药物的肝脏清除?","authors":"Patrick Poulin","doi":"10.1016/j.xphs.2025.103827","DOIUrl":null,"url":null,"abstract":"<p><p>As the hepatic clearance (CL<sub>H</sub>) of drugs becomes independent of hepatic blood flow rate, CL<sub>H</sub> depends primarily on intrinsic clearance (CL<sub>int</sub>). Incubations of microsomes or hepatocytes are commonly used to generate CL<sub>int</sub>. Therefore, CL<sub>int</sub> estimates corrected for binding to the in vitro systems and scaled to whole liver, are applied to a well-stirred liver model to obtain CL<sub>H</sub> predictions for drugs. In other words, CL<sub>int</sub> is extrapolated with the ratio of unbound fraction between the plasma (fu<sub>p</sub>) and incubation medium (fu<sub>inc</sub>). However, this binding correction resulted to an important underprediction bias of CL<sub>H</sub>. Therefore, the approach considering fu<sub>p</sub> and fu<sub>inc</sub> needs to be better understood for more precisely scaling CL<sub>int</sub>. The objective of this study was to explain the underprediction bias of CL<sub>H</sub> based on physicochemical properties of drugs. Analysis-ready datasets have been collected so that evaluation of the data generates a mechanistic understanding of the impact of unbound fraction on the prediction of CL<sub>H</sub> of human for 128 drugs. Experimental values of fu<sub>inc</sub> for liver are quantifying solely the binding to lipids in microsomes or hepatocytes in the absence of plasma proteins in the incubations. However, the experimental values of fu<sub>p</sub> for plasma can estimate the binding to lipids and plasma proteins. Therefore, drugs binding primarily to lipids in the liver and plasma showed a less pronounced underprediction bias of CL<sub>H</sub> by using the ratios of fu<sub>p</sub>/fu<sub>inc</sub> in the well-stirred model. In contrast, drugs binding primarily to the plasma proteins in the liver and plasma showed a larger underprediction bias of CL<sub>H</sub>. Furthermore, for the ionized drugs, values of fu<sub>p</sub> and fu<sub>inc</sub> are not covering the pH gradient effect between plasma and hepatocytes, which also impacted the CL<sub>H</sub> predictions. For these reasons, a mechanistic approach was proposed to replace the conventional fu<sub>p</sub> value with an adjusted fu<sub>p</sub> (fu<sub>-adjusted</sub>) that accounts for differences in proteins/lipids binding and pH gradient effect between the liver and plasma. Hence, replacing fu<sub>p</sub> with fu<sub>-adjusted</sub> did provide a universal and mechanisms-based approach removing the underprediction bias for all datasets of drugs. Overall, this study indicates which drug properties generated the largest underprediction bias of CL<sub>H</sub> and suggests that the Poulin et al. method referring to fu<sub>-adjusted</sub> could be the most proper unbound fraction to reduce that bias with the well-stirred model.</p>","PeriodicalId":16741,"journal":{"name":"Journal of pharmaceutical sciences","volume":" ","pages":"103827"},"PeriodicalIF":3.7000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Which Unbound Fraction Should We Use in the Well-Stirred Model for More Accurately Predicting Hepatic Clearance of Drugs for Humans?\",\"authors\":\"Patrick Poulin\",\"doi\":\"10.1016/j.xphs.2025.103827\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>As the hepatic clearance (CL<sub>H</sub>) of drugs becomes independent of hepatic blood flow rate, CL<sub>H</sub> depends primarily on intrinsic clearance (CL<sub>int</sub>). Incubations of microsomes or hepatocytes are commonly used to generate CL<sub>int</sub>. Therefore, CL<sub>int</sub> estimates corrected for binding to the in vitro systems and scaled to whole liver, are applied to a well-stirred liver model to obtain CL<sub>H</sub> predictions for drugs. In other words, CL<sub>int</sub> is extrapolated with the ratio of unbound fraction between the plasma (fu<sub>p</sub>) and incubation medium (fu<sub>inc</sub>). However, this binding correction resulted to an important underprediction bias of CL<sub>H</sub>. Therefore, the approach considering fu<sub>p</sub> and fu<sub>inc</sub> needs to be better understood for more precisely scaling CL<sub>int</sub>. The objective of this study was to explain the underprediction bias of CL<sub>H</sub> based on physicochemical properties of drugs. Analysis-ready datasets have been collected so that evaluation of the data generates a mechanistic understanding of the impact of unbound fraction on the prediction of CL<sub>H</sub> of human for 128 drugs. Experimental values of fu<sub>inc</sub> for liver are quantifying solely the binding to lipids in microsomes or hepatocytes in the absence of plasma proteins in the incubations. However, the experimental values of fu<sub>p</sub> for plasma can estimate the binding to lipids and plasma proteins. Therefore, drugs binding primarily to lipids in the liver and plasma showed a less pronounced underprediction bias of CL<sub>H</sub> by using the ratios of fu<sub>p</sub>/fu<sub>inc</sub> in the well-stirred model. In contrast, drugs binding primarily to the plasma proteins in the liver and plasma showed a larger underprediction bias of CL<sub>H</sub>. Furthermore, for the ionized drugs, values of fu<sub>p</sub> and fu<sub>inc</sub> are not covering the pH gradient effect between plasma and hepatocytes, which also impacted the CL<sub>H</sub> predictions. For these reasons, a mechanistic approach was proposed to replace the conventional fu<sub>p</sub> value with an adjusted fu<sub>p</sub> (fu<sub>-adjusted</sub>) that accounts for differences in proteins/lipids binding and pH gradient effect between the liver and plasma. Hence, replacing fu<sub>p</sub> with fu<sub>-adjusted</sub> did provide a universal and mechanisms-based approach removing the underprediction bias for all datasets of drugs. Overall, this study indicates which drug properties generated the largest underprediction bias of CL<sub>H</sub> and suggests that the Poulin et al. method referring to fu<sub>-adjusted</sub> could be the most proper unbound fraction to reduce that bias with the well-stirred model.</p>\",\"PeriodicalId\":16741,\"journal\":{\"name\":\"Journal of pharmaceutical sciences\",\"volume\":\" \",\"pages\":\"103827\"},\"PeriodicalIF\":3.7000,\"publicationDate\":\"2025-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of pharmaceutical sciences\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.xphs.2025.103827\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"CHEMISTRY, MEDICINAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of pharmaceutical sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.xphs.2025.103827","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
Which Unbound Fraction Should We Use in the Well-Stirred Model for More Accurately Predicting Hepatic Clearance of Drugs for Humans?
As the hepatic clearance (CLH) of drugs becomes independent of hepatic blood flow rate, CLH depends primarily on intrinsic clearance (CLint). Incubations of microsomes or hepatocytes are commonly used to generate CLint. Therefore, CLint estimates corrected for binding to the in vitro systems and scaled to whole liver, are applied to a well-stirred liver model to obtain CLH predictions for drugs. In other words, CLint is extrapolated with the ratio of unbound fraction between the plasma (fup) and incubation medium (fuinc). However, this binding correction resulted to an important underprediction bias of CLH. Therefore, the approach considering fup and fuinc needs to be better understood for more precisely scaling CLint. The objective of this study was to explain the underprediction bias of CLH based on physicochemical properties of drugs. Analysis-ready datasets have been collected so that evaluation of the data generates a mechanistic understanding of the impact of unbound fraction on the prediction of CLH of human for 128 drugs. Experimental values of fuinc for liver are quantifying solely the binding to lipids in microsomes or hepatocytes in the absence of plasma proteins in the incubations. However, the experimental values of fup for plasma can estimate the binding to lipids and plasma proteins. Therefore, drugs binding primarily to lipids in the liver and plasma showed a less pronounced underprediction bias of CLH by using the ratios of fup/fuinc in the well-stirred model. In contrast, drugs binding primarily to the plasma proteins in the liver and plasma showed a larger underprediction bias of CLH. Furthermore, for the ionized drugs, values of fup and fuinc are not covering the pH gradient effect between plasma and hepatocytes, which also impacted the CLH predictions. For these reasons, a mechanistic approach was proposed to replace the conventional fup value with an adjusted fup (fu-adjusted) that accounts for differences in proteins/lipids binding and pH gradient effect between the liver and plasma. Hence, replacing fup with fu-adjusted did provide a universal and mechanisms-based approach removing the underprediction bias for all datasets of drugs. Overall, this study indicates which drug properties generated the largest underprediction bias of CLH and suggests that the Poulin et al. method referring to fu-adjusted could be the most proper unbound fraction to reduce that bias with the well-stirred model.
期刊介绍:
The Journal of Pharmaceutical Sciences will publish original research papers, original research notes, invited topical reviews (including Minireviews), and editorial commentary and news. The area of focus shall be concepts in basic pharmaceutical science and such topics as chemical processing of pharmaceuticals, including crystallization, lyophilization, chemical stability of drugs, pharmacokinetics, biopharmaceutics, pharmacodynamics, pro-drug developments, metabolic disposition of bioactive agents, dosage form design, protein-peptide chemistry and biotechnology specifically as these relate to pharmaceutical technology, and targeted drug delivery.